OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
11.51
-0.13 (-1.12%)
Jan 27, 2026, 1:53 PM EST - Market open
OptimizeRx Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$19.67
Upside
+70.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $20 → $17 | Hold | Maintains | $20 → $17 | +47.70% | Nov 17, 2025 |
| Citizens | Citizens | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +108.51% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +99.83% | Oct 10, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +73.76% | Aug 11, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +56.39% | Aug 8, 2025 |
| Stifel | Stifel | Strong Buy Maintains $13 → $16 | Strong Buy | Maintains | $13 → $16 | +39.01% | Jun 9, 2025 |
| Stifel | Stifel | Strong Buy Maintains $8 → $13 | Strong Buy | Maintains | $8 → $13 | +8.60% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +21.63% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | -30.50% | Feb 6, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $7 → $6 | Buy → Hold | Downgrades | $7 → $6 | -47.87% | Jan 8, 2025 |
| Lake Street | Lake Street | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -4.43% | Dec 24, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $17 → $13 | Strong Buy | Maintains | $17 → $13 | +12.95% | Dec 24, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $5.5 | Hold | Initiates | $5.5 | -52.22% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $16 → $8 | Buy | Maintains | $16 → $8 | -30.50% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $7 | Buy | Maintains | $14 → $7 | -39.18% | Nov 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $16 | Strong Buy | Reiterates | $20 → $16 | +39.01% | Nov 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.